EFHC1 anticorps (AbBy Fluor® 594)

N° du produit ABIN2812685

Détail du produit anti-EFHC1 anticorps (AbBy Fluor® 594)

Antigène: EFHC1 (EF-Hand Domain (C-terminal) Containing 1 (EFHC1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EFHC1 est conjugé à/à la AbBy Fluor® 594

Application: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Humain, Souris, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human EFHC1

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur EFHC1

Antigène: EFHC1 (EF-Hand Domain (C-terminal) Containing 1 (EFHC1))

Autre désignation: EFHC1 (EFHC1 Produits)

Synonymes: anticorps MGC63931, anticorps zgc:63931, anticorps MGC84469, anticorps MGC89313, anticorps dJ304B14.2, anticorps 1700029F22Rik, anticorps mRib72-1, anticorps myoclonin1, anticorps EF-hand domain containing 1, anticorps EF-hand domain (C-terminal) containing 1, anticorps EF-hand domain (C-terminal) containing 1 L homeolog, anticorps Efhc1, anticorps EFHC1, anticorps efhc1, anticorps efhc1.L

Sujet:

Synonyms: EF hand domain C terminal containing 1, EF hand domain containing protein 1, EF-hand domain-containing protein 1, Efhc1, EFHC1_HUMAN, EJA1, EJM1, FLJ10466, FLJ37290, JAE, Myoclonin 1, Myoclonin-1.

Background: Defects in EFHC1 are the cause of juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770]. EJM1 is a subtype of idiopathic generalized epilepsy (IGE). Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue.Genetic variations in EFHC1 are the cause of susceptibility to juvenile absence epilepsy type 1 (JAE1) . JAE is a subtype of idiopathic generalized epilepsy characterized by onset occurring around puberty, absence seizures, generalized tonic-clonic seizures (GTCS), GTCS on awakening, and myoclonic seizures.

ID gène: 114327